Ignore-the-FDA-and-buy-Acrux, page-10

First 10 Last

Share
Profile

Follow
jazzapat

587 Posts.

79

17/06/14

15:13

Post #: 13535036
Share

Originally posted by Evetsgold ↑

I won't post the II article, as I'm sure its some sort of breach of membership, but essentially what it says is:
The FDA concerns may be overblown.
Superior product to the competitor.
TRT market is exploding.
Lilly is a powerful marketing partner.
Tax free dividends & capital growth.

Essentially they are saying the bears have only seen the bad news, but there are plenty of opportunities here. The price offered far outweighs the risks. They have a buy of under $0.90 and a sell above $3.

Intelligent Investor have got into quite a few small caps now, and with a large member base, you tend to see their recommendations affect share price significantly. I've just seen ACR hit $1.03. I bought soon after the article was posted (@ $0.82). No doubt part of this price gain is due to the II article. Don't be surprised to see it back at $0.80 in a couple of weeks once the dust settles. Have a look at Somnomed (SOM), it went from $1.35 to $1.65 within a few days of II slapping a buy on it, and now sits at $1.46.

Expand

I doubt the II report has been the only driver, volume to high in my view. Something else at play potentially, but who knows.

ACR Price at posting: $1.05 Sentiment: None Disclosure: Unspecified
Upvote

0 Great analysis

Reply

Top Stories

Uranium ignites: Is this the start of a supercycle?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

ASX Market Close: Middle East War rattles investors | June 23, 2025

Markets were expecting Trump to bomb Iran. It's just another new normal

SFX

Sheffield Resources spruiks 'pleasing' maiden MRE at South Atlantic Project

First 10 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.8¢		Change -0.001(5.26%)		Mkt cap ! $7.339M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.8¢	$11.58K	619.2K

Buyers (Bids)

No.	Vol.	Price($)
4	335415	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	516258	1

View Market Depth

No.	Vol.	Price($)
4	335415	0.018
1	175000	0.017
1	66732	0.015
1	70000	0.014
1	297000	0.013

Price($)	Vol.	No.
0.019	516258	1
0.020	80000	3
0.021	177000	1
0.022	118000	2
0.023	73278	3

Last trade - 16.10pm 23/06/2025 (20 minute delay)

ACR (ASX) Chart

Ignore-the-FDA-and-buy-Acrux, page-10

Uranium ignites: Is this the start of a supercycle?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

ASX Market Close: Middle East War rattles investors | June 23, 2025

Markets were expecting Trump to bomb Iran. It's just another new normal

Sheffield Resources spruiks 'pleasing' maiden MRE at South Atlantic Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ignore-the-FDA-and-buy-Acrux, page-10

Top Stories

Uranium ignites: Is this the start of a supercycle?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

ASX Market Close: Middle East War rattles investors | June 23, 2025

Markets were expecting Trump to bomb Iran. It's just another new normal

Sheffield Resources spruiks 'pleasing' maiden MRE at South Atlantic Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News